Metformin Mimics Exercise Benefits for Prostate Cancer Patients

A recent study conducted by physician-scientists at the Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, has revealed that metformin, a widely prescribed diabetes medication, can replicate some of the metabolic benefits of exercise in men undergoing treatment for prostate cancer. Published in *EMBO Molecular Medicine*, the research highlights how metformin elevates levels of N-lactoyl-phenylalanine (Lac-Phe), a metabolite associated with energy balance and weight regulation, even in patients who are physically inactive.

Study Finds Diabetes Drug Metformin May Mimic Exercise Benefits in ProstateDiabetes Drug Mimics Benefits of Exercise in Prostate Cancer PatientsStudy: Diabetes drug, metformin, may echo the benefits of exercise in prostate cancer care

Prostate cancer patients often face significant metabolic challenges due to hormone therapy, which can lead to weight gain, insulin resistance, and cardiovascular issues. Regular exercise is known to mitigate these effects, but many patients experience fatigue and other symptoms that limit their ability to engage in physical activity. The study's findings suggest that metformin may provide a pharmacological alternative to exercise by activating similar metabolic pathways.

Study Finds Diabetes Drug Metformin May Mimic Exercise Benefits in ProstateStudy: Diabetes drug, metformin, may echo the benefits of exercise in prostate cancer care

Lac-Phe is produced when lactate, which accumulates during physical exertion, combines with phenylalanine, an amino acid. Previous studies have shown that Lac-Phe levels spike after intense exercise, correlating with reduced appetite and improved weight control. The Sylvester team found that prostate cancer patients taking metformin exhibited Lac-Phe levels comparable to those seen after strenuous exercise, despite not engaging in physical activity at the time of blood collection.

Study Finds Diabetes Drug Metformin May Mimic Exercise Benefits in ProstateDiabetes Drug Mimics Benefits of Exercise in Prostate Cancer PatientsStudy: Diabetes drug, metformin, may echo the benefits of exercise in prostate cancer care

This elevation in Lac-Phe levels persisted even after the initiation of hormone therapy, indicating that metformin may help alleviate metabolic strain through mechanisms similar to those activated by exercise. However, it is important to note that higher Lac-Phe levels did not correlate with anti-tumor responses, as measured by prostate-specific antigen (PSA) levels.

Study: Diabetes drug, metformin, may echo the benefits of exercise in prostate cancer careStudy Finds Diabetes Drug Metformin May Mimic Exercise Benefits in ProstateDiabetes Drug Mimics Benefits of Exercise in Prostate Cancer Patients

The implications of these findings extend beyond tumor targeting to encompass a holistic approach to cancer care. Supporting metabolic health is crucial for improving treatment tolerance and overall quality of life for patients undergoing hormone therapy. As Priyamvada Rai, Ph.D., co-leader of the Tumor Biology Program at Sylvester, stated, “Cancer therapy often affects the body in ways that go beyond the tumor.”

Study Finds Diabetes Drug Metformin May Mimic Exercise Benefits in Prostate

The study emphasizes the importance of understanding how treatments affect metabolism, which can lead to strategies that help patients maintain strength and resilience throughout their care. Researchers are optimistic that Lac-Phe could serve as a biomarker for metabolic engagement, guiding therapeutic strategies aimed at mitigating metabolic dysfunction during cancer treatment.

Study Finds Diabetes Drug Metformin May Mimic Exercise Benefits in Prostate

While the findings are promising, further research is needed to explore the mechanistic roles of Lac-Phe and its potential as a therapeutic target. The study's authors caution that metformin should not be viewed as a replacement for physical activity but rather as a complementary approach for patients unable to exercise due to their condition.

Study Finds Diabetes Drug Metformin May Mimic Exercise Benefits in Prostate

Looking ahead, the research community aims to investigate how metformin and similar drugs can be utilized to enhance metabolic health in prostate cancer patients, potentially transforming supportive care practices in oncology.

Study Finds Diabetes Drug Metformin May Mimic Exercise Benefits in ProstateMetformin May Mimic Exercise Benefits for Men with Prostate Cancer

• “From a clinical standpoint, seeing a metabolic signal that mirrors what we associate with intense exercise was striking,” — Marijo Bilusic, M.D., Ph.D., Professor of Medicine and Medical Oncology

Study: Diabetes drug, metformin, may echo the benefits of exercise in prostate cancer care

• “What’s encouraging about this work is that it reminds us cancer care isn’t only about targeting tumors—it’s also about supporting the whole patient,” — Priyamvada Rai, Ph.D., Professor of Radiation Oncology

Study: Diabetes drug, metformin, may echo the benefits of exercise in prostate cancer care

This study marks a significant advancement in understanding the interplay between cancer therapies and metabolism, offering hope for improved patient outcomes through enhanced metabolic support.

Study Finds Diabetes Drug Metformin May Mimic Exercise Benefits in Prostate